Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
PaperCitations, authors & open-access status
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 348 citations, 2009 year and bronze oa status.
348
Citations
2009
Year
bronze
OA Status